1. Search Result
Search Result
Results for "

GAT-3

" in MedChemExpress (MCE) Product Catalog:

22

Inhibitors & Agonists

2

Natural
Products

1

Recombinant Proteins

5

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0696

    NO050328; NO328; TGB

    GABA Receptor Neurological Disease
    Tiagabine (NO050328; NO328; TGB) is an orally active, highly selective, and reversible GAT-1 inhibitor and anticonvulsant that crosses the blood-brain barrier. By blocking the reuptake of GABA in neurons and glial cells, tiagabine increases extracellular GABA levels to enhance inhibitory signal transduction, thereby exerting multiple activities such as anticonvulsant, neuroprotective, and antioxidant effects. Tiagabine exhibits linear pharmacokinetic properties. Although it is metabolized by CYP3A and has a high protein binding rate, it carries a low risk of cognitive impairment. Tiagabine is widely used in research on related diseases including epilepsy (including refractory partial seizures), alcohol withdrawal symptoms, and Huntington's disease [3] .
    Tiagabine
  • HY-100228A

    d,l-SKF89976A hydrochloride

    GABA Receptor Neurological Disease
    SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.
    SKF89976A hydrochloride
  • HY-100809
    Guvacine hydrochloride
    1 Publications Verification

    GABA Receptor Neurological Disease
    Guvacine hydrochloride is an alkaloid from the nut of Areca catechu, acts as an inhibitor of GABA transporter, and dispalys modest selectivity for cloned GABA transporters with IC50s of 14 μM (human GAT-1), 39 μM (rat GAT-1), 58 μM (rat GAT-2), 119 μM (human GAT-3), 378 μM (rat GAT-3), and 1870 μM (human BGT-3).
    Guvacine hydrochloride
  • HY-N2482A
    Guvacine hydrobromide
    1 Publications Verification

    GABA Receptor Neurological Disease
    Guvacine hydrobromide, an alkaloid found in the nut of Areca catechu, is a potent GABA uptakp inhibitor. Guvacine hydrobromide inhibits rat GAT-1, rat GAT-2 and rat GAT-3 with IC50 values of 39 μM, 58 μM and 378 μM, respectively .
    Guvacine hydrobromide
  • HY-103534

    GABA Receptor Neurological Disease
    CI-966 hydrochloride is a potent, selective, orally active and brain-penetrant inhibitor of the GABA transporter GAT-1, with IC50s of 0.26 μM and 1.2 μM for hGAT-1, rGAT-1, respectively. CI-966 hydrochloride shows more than 200-fold selectivity over GAT-2, GAT-3, and BGT-3. CI-966 hydrochloride exhibits anticonvulsant and neuroprotective activities [3].
    CI-966 hydrochloride
  • HY-N2482

    GABA Receptor Neurological Disease
    Guvacine, an alkaloid found in the nut of Areca catechu, is a potent GABA uptakp inhibitor. Guvacine inhibits rat GAT-1, rat GAT-2 and rat GAT-3 with IC50 values of 39 μM, 58 μM and 378 μM, respectively .
    Guvacine
  • HY-124285

    GABA Receptor Others
    ATPCA hydrochloride is a selective radioactive substrate for BGT1 over GAT1/GAT3 .
    ATPCA hydrochloride
  • HY-177796

    Apoptosis CDK Caspase PARP Cancer
    TMLB-C16 is a potent and orally active B3GAT3 inhibitor with a KD of 3.962 μM. TMLB-C16 suppresses proliferation and migration, and induces cell cycle arrest and apoptosis in MHCC-97H (IC50 = 6.53 μM) and HCCLM3 cells (IC50 = 6.22 μM). TMLB-C16 inhibits tumor growth in both MHCC-97H and HCCLM3 xenograft tumor mouse models without causing obvious toxicity. TMLB-C16 can be used for hepatocellular carcinoma research .
    TMLB-C16
  • HY-100228

    GABA Receptor Neurological Disease
    SKF89976A is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.
    SKF 89976A
  • HY-RS25183

    Small Interfering RNA (siRNA) Others

    B3gat3 Rat Pre-designed siRNA Set A contains three designed siRNAs for B3gat3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    B3gat3 Rat Pre-designed siRNA Set A
    B3gat3 Rat Pre-designed siRNA Set A
  • HY-RS01308

    Small Interfering RNA (siRNA) Others

    B3GAT3 Human Pre-designed siRNA Set A contains three designed siRNAs for B3GAT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    B3GAT3 Human Pre-designed siRNA Set A
    B3GAT3 Human Pre-designed siRNA Set A
  • HY-123240

    GABA Receptor Neurological Disease
    CI-966 is a potent, selective, orally active and brain-penetrant inhibitor of the GABA transporter GAT-1, with IC50s of 0.26 μM and 1.2 μM for hGAT-1, rGAT-1, respectively. CI-966 shows more than 200-fold selectivity over GAT-2, GAT-3, and BGT-3. CI-966 exhibits anticonvulsant and neuroprotective activities [3].
    CI-966
  • HY-RS13297

    Small Interfering RNA (siRNA) Others

    SLC6A11 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC6A11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SLC6A11 Human Pre-designed siRNA Set A
    SLC6A11 Human Pre-designed siRNA Set A
  • HY-RS13299

    Small Interfering RNA (siRNA) Others

    SLC6A13 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC6A13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SLC6A13 Human Pre-designed siRNA Set A
    SLC6A13 Human Pre-designed siRNA Set A
  • HY-182944

    GABA Receptor Neurological Disease
    GATT-44 is a blood-brain barrier-permeable, selective GABA transporter 1 (GAT-1) ligand with an IC50 of 126 nM. GATT-44 shows selectivity for GAT-2, GAT-3 and BGT-1 subtypes, and undergoes copper-mediated 18F-radiofluorination. The radiolabeled GATT-44 ([ 18F]GATT-44) exhibits brain uptake, metabolic stability and high GAT-1 binding specificity in non-human primates. GATT-44 is applicable for research on neurodegenerative and neuropsychiatric diseases .
    GATT-44
  • HY-RS18696

    Small Interfering RNA (siRNA) Others

    B3gat3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for B3gat3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    B3gat3 Mouse Pre-designed siRNA Set A
    B3gat3 Mouse Pre-designed siRNA Set A
  • HY-100228AR

    d,l-SKF89976A hydrochloride (Standard)

    GABA Receptor Reference Standards Neurological Disease
    SKF89976A (hydrochloride) (Standard) is the analytical standard of SKF89976A (hydrochloride) (HY-100228A). This product is intended for research and analytical applications. SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.
    SKF89976A hydrochloride (Standard)
  • HY-W033027

    GABA Receptor Neurological Disease
    BGT1-IN-1 (compound 9) is a potent BGT1 inhibitor with IC50 value of 13.9, 58.3 µM for hBGT1, GAT3, respectively. BGT1-IN-1 shows no cytotoxic. BGT1-IN-1 shows neuroprotective activity .
    BGT1-IN-1
  • HY-181961

    GABA Receptor Cardiovascular Disease Neurological Disease
    SR-THAP is a γ-aminobutyric acid transporter 3 (GAT3) inhibitor with an IC50 of 4.9 μM, and exhibits 42-fold and 23-fold selectivity over GAT1 and GlyT1, respectively. SR-THAP inhibits GABA uptake in mammalian cells. SR-THAP is applicable to the research of epilepsy, Alzheimer's disease and ischemic stroke .
    SR-THAP
  • HY-103534R

    Reference Standards GABA Receptor Neurological Disease
    CI-966 hydrochloride (Standard) is the analytical standard of CI-966 hydrochloride (HY-103534). This product is intended for research and analytical applications. CI-966 hydrochloride is a potent, selective, orally active and brain-penetrant inhibitor of the GABA transporter GAT-1, with IC50s of 0.26 μM and 1.2 μM for hGAT-1, rGAT-1, respectively. CI-966 hydrochloride shows more than 200-fold selectivity over GAT-2, GAT-3, and BGT-3. CI-966 hydrochloride exhibits anticonvulsant and neuroprotective activities [3].
    CI-966 hydrochloride (Standard)
  • HY-181135

    GABA Receptor Neurological Disease
    Bicyclo-GABA is a selective betaine/GABA transporter 1 (BGT1) competitive, non-transported inhibitor with an IC50 of 590 nM. Bicyclo-GABA exhibits low micromolar agonistic activity at α1β2γ2 GABAA receptors with an EC50 of 5.1 μM. Bicyclo-GABA displays 129 times higher activity for BGT1 than GAT3. Bicyclo-GABA serves as a valuable tool compound for deciphering its elusive pharmacological role in the brain and periphery .
    Bicyclo-GABA
  • HY-181753

    Creatine Kinase Amino acid Transporter Inflammation/Immunology Cancer
    INSP-0154 is a potent creatine kinase B (CKB)/creatine transporter (SLC6A8) inhibitor. INSP-0154 binds to the SLC6A8 occluded pocket, prevents creatine transport into cells, and protects SLC6A8 cysteine residue C144 from irreversible inactivation. INSP-0154 inhibits creatine uptake in mouse heart tissue. INSP-0154 can be used for the research of cancer .
    INSP-0154

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: